Ample evidence suggests that CD4+ T cells facilitate the activation and development of anti-tumor responses of CD8+ T cells by enhancing clonal expansion at the tumor site, preventing activation-induced cell death and functioning as antigen-presenting cells for CTLs to preferentially generate immune memory cells [10]. The gene discussed is CD8A; the disease is neoplasm.